The Role of Ampligen in Strategic Therapeutic Intervention (STI) of Highly Active Anti-Retroviral Therapy (HAART): A Multi-Center, Randomized, Controlled Study of Ampligen Potentiation of the HAART-Free Interval.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Rintatolimod (Primary)
- Indications Severe acute respiratory syndrome
- Focus Therapeutic Use
- Sponsors AIM ImmunoTech; Hemispherx Biopharma
- 13 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Oct 2005 New trial record.